Delivery Order SPE2DB24D1205-SPE2DB24FCSPU

Award Date 7/9/24
Potential Completion Date 7/30/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $76,698.42 Firm Fixed Price delivery order is for the drug SKYRIZI 150 MG/ML PENML. The contract has an ultimate completion date of March 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,827.51 firm-fixed-price delivery order is for the supply of the drug Skyrizi (360 mg/2.4 ml) to support federal healthcare programs. The award has a completion date of September 13, 2024 and is not set aside for any special business categories. Amerisourcebergen has been awarded numerous Indefinite Delivery Contracts (IDCs) by the DLA and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,103.41, is a delivery order for the supply of Skyrizi 150 mg/ml pre-filled syringes. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp., a major pharmaceutical distributor, is for the delivery of a specialty medication called SKYRIZI 180 MG/1.2 ML. The $11,827.51 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, on July 26, 2024, with a completion date of August 16, 2024. The contract does not have a set-aside designation, indicating it was an open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $55,121.07 firm fixed-price delivery order is for the supply of Skyrizi 150 mg/ml syringes. The contract has an ultimate completion date of January 6, 2025 and was awarded on January 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of SKYRIZI 150 MG/ML PENML medication. The contract has a ceiling value of $11,827.51 and an ultimate completion date of June 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is a delivery order with a firm fixed price of $26,918.72 and a performance period through May 2025. The award is not set aside and covers the supply of the pharmaceutical product SKYRIZI 150 MG/ML PENML. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $12,604.63, is for the delivery of the drug Skyrizi (180 mg/1.2 ml on-body) with a final completion date of February 11, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $16,414.61, is a Firm Fixed Price Delivery Order for the supply of SKYRIZI 150 MG/ML PENML medical products. The contract has an ultimate completion date of January 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,604.63 Firm Fixed Price Delivery Order contract is for the supply of the prescription medication Skyrizi (360 mg/2.4 ml on-body 2.4 ml). The contract has an ultimate completion date of April 29, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCSPU
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, is for the delivery of the drug Skyrizi (180 mg/1.2 ml) to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $11,827.51 and an ultimate completion date of July 30, 2024.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award does not have a set-aside designation.

Generated 10/8/24, 9:19 AM